You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Cancer Screening

The PMC reviewed relevant performance measures and makes the following recommendations.

November 2018 printable version of recommendations.
Printable version of the recommendations.

ACP supports this measure.

ID# MIPS 320
NQF 0658

More Information

Appropriate Follow-up Interval for Normal Colonoscopy in Average Risk Patients

Percentage of patients aged 50 years to 75 years receiving a screening colonoscopy without biopsy or polypectomy who had a recommended follow-up interval of at least 10 years for repeat colonoscopy documented in their colonoscopy report.
Date Reviewed: November 4, 2018

ACP supports this measure with modifications.

ID# MIPS 439

More Information

Age Appropriate Screening Colonoscopy

The percentage of patients greater than 85 years of age who received a screening colonoscopy from January 1 to December 31.
Date Reviewed: November 4, 2018

ACP supports this measure.

ID# MIPS 112
ID# NQF 2372

More Information

Breast Cancer Screening

The percentage of women 50-74 years of age who had a mammogram to screen for breast cancer.
Date Reviewed: November 4, 2018

ACP supports this measure.

ID# QPP/MIPS 443:
Not NQF-endorsed

More Information

Non-recommended Cervical Cancer Screening in Adolescent Females

The percentage of adolescent females 16-20 years of age who were screened unnecessarily for cervical cancer.
Date Reviewed: November 19, 2017

ACP supports this measure.

ID# QPP 113
ID# NQF 0034

More Information

Colorectal Cancer Screening

The percentage of patients 50-75 years of age who had appropriate screening for colorectal cancer.
Date Reviewed: November 19, 2017

ACP supports this measure.

ID# QPP 309
ID# NQF 0032

More Information

Cervical Cancer Screening (CCS)

Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:

  • Women age 21-64 who had cervical cytology performed every 3 years.
  • Women age 30-64 who had cervical cytology/human papillomavirus (HPV) co-testing performed every 5 years.

Date Reviewed: November 19, 2017

ACP supports this measure.

ID# NQF 0659

More Information

Colonoscopy Interval for Patients with a History of Adenomatous Polyps-Avoidance of Inappropriate Use

Percentage of patients aged 18 years and older receiving a surveillance colonoscopy, with a history of a prior colonic polyp(s) in previous colonoscopy findings, who had an interval of 3 or more years since their last colonoscopy.
Date Reviewed: November 7, 2015

ACP supports this measure.

ID# NQF 0579

More Information

Annual cervical cancer screening or follow-up in high-risk women

This measure identifies women age 12 to 65 diagnosed with cervical dysplasia (CIN 2), cervical carcinoma-in-situ, or HIV/AIDS prior to the measurement year, and who still have a cervix, who had a cervical CA screen during the measurement year.
Date Reviewed: November 7, 2015